alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › questions

questions

3 studies tagged questions, dated 1989-01-01 to 2026-08-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Further data to address the Alzheimer's coverage with evidence development questions 2026-08-01
  2. Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease 2023-06-02
  3. Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? 1989-01-01

Studies

3 studies carry this tag.

Date range

1989 to 2026

Top journals

  • Acta neurologica Scandinavica. Supplementum 1
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Brain communications 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Further data to address the Alzheimer's coverage with evidence development questions

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2026-08-01 Treatments

    With CED questions addressed, reconsideration of the class-based NCD is scientifically justified.

  2. Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Brain communications 2023-06-02 Treatments

    The clinical benefit associated with anti-amyloid immunotherapies, a new class of drugs for the treatment of Alzheimer's disease, is predicated on their ability to modify disease course by lowering brain amyloid levels.

  3. Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Acta neurologica Scandinavica. Supplementum 1989-01-01 Tau biomarkers

    Radicals are species containing one or more unpaired electrons.

All topic tags with their study counts